<DOC>
	<DOCNO>NCT00921258</DOCNO>
	<brief_summary>This study concern prospective cohort pf patient latent prostate cancer . We study specific survival 10 year patient accept active control.Patients inclusion realize 2 stage : - patient inclusion criterion ( PSA &lt; 10 ng/ml , clinical stage T1c T2a , Gleason &lt; = 6 ) register accept second prostate biopsy 3 month delay - analyse second biopsy central laboratory confirmation latent prostate biopsy , patient include accept active control Included patient 1 biopsy year first two year 1 biopsy 2 year 8 year . If progression cancer happen 10 year control , active control stop patient treat surgery chemotherapy .</brief_summary>
	<brief_title>Active Control Prostatic Cancer With Criteria Latence</brief_title>
	<detailed_description>This study concern active control 10 year patient latent prostate cancer accept treat immediately .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>patient latent prostatic cancer age less 75 year old , life expectation high 10 year Clinic statue T1c T2a seric PSA ( prostatic specific antigen ) small 10ng/ml 10 biopsy core sample patient less 3 core sample tumor none care sample 3mm tumor Gleason score inferior 7 patient 's agreement project second biopsy include definitive patient : realize 3 month first : 14 biopsy core sample ( 10 like previously 4 specific : take around positive initial biopsy ) , less 3 core sample tumor , , core sample 3mm tumor , Gleason score superior 7. patient age 75 year old patient 's agreement lack understanding plan patient guardianship life expectation small 10 year patient cancer le 5 year Local clinical statue great T2a seric PSA high 10ng/ml less 10 biopsy 2 positive biopsy first intervention 3 core sample 3mm tumor 4th grade biopsy patient 's refuse realize second biopsy patient ask treatment first medical examination patient le 4 special biopsy around previously initial core sample 2 positive biopsy biopsy 3mm tumor patient 4 grade biopsy , second medical examination .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>latent prostate cancer</keyword>
	<keyword>Patient latent prostate cancer</keyword>
	<keyword>PSA â‰¤ 10 ng/ml</keyword>
	<keyword>Clinical stage T1c T2a</keyword>
	<keyword>Patient accept control</keyword>
</DOC>